- Open Access
Cerebral malaria induces electrophysiological and neurochemical impairment in mice retinal tissue: possible effect on glutathione and glutamatergic system
© The Author(s) 2017
- Received: 24 February 2017
- Accepted: 23 October 2017
- Published: 2 November 2017
Cerebral malaria (CM) is a severe complication resulting from Plasmodium falciparum infection. This condition has usually been associated with cognitive, behavioural and motor dysfunctions, being the retinopathy the most serious consequence resulting from the disease. The pathophysiological mechanisms underlying this complication remain incompletely understood. Several experimental models of CM have already been developed in order to clarify those mechanisms related to this syndrome. In this context, the present work has been performed to investigate which possible electrophysiological and neurochemistry alterations could be involved in the CM pathology.
Experimental CM was induced in Plasmodium berghei-infected male and female C57Bl/6 mice. The survival and neurological symptoms of CM were registered. Brains and retina were assayed for TNF levels and NOS2 expression. Electroretinography measurements were recorded to assessed a- and b-wave amplitudes and neurochemicals changes were evaluated by determination of glutamate and glutathione levels by HPLC.
Susceptible C57Bl/6 mice infected with ≈ 106 parasitized red blood cells (P. berghei ANKA strain), showed a low parasitaemia, with evident clinical signs as: respiratory failure, ataxia, hemiplegia, and coma followed by animal death. In parallel to the clinical characterization of CM, the retinal electrophysiological analysis showed an intense decrease of a- and-b-wave amplitude associated to cone photoreceptor response only at the 7 days post-infection. Neurochemical results demonstrated that the disease led to a decrease in the glutathione levels with 2 days post inoculation. It was also demonstrated that the increase in the glutathione levels during the infection was followed by the increase in the 3H-glutamate uptake rate (4 and 7 days post-infection), suggesting that CM condition causes an up-regulation of the transporters systems. Furthermore, these findings also highlighted that the electrophysiological and neurochemical alterations occurs in a manner independent on the establishment of an inflammatory response, once tumour necrosis factor levels and inducible nitric oxide synthase expression were altered only in the cerebral tissue but not in the retina.
In summary, these findings indicate for the first time that CM induces neurochemical and electrophysiological impairment in the mice retinal tissue, in a TNF-independent manner.
- Cerebral malaria
- Glutamate uptake
- Electroretinogram and cone photoreceptor response
Cerebral malaria (CM) is one of the major complication of Plasmodium falciparum infection and even with optimal anti-malarial treatment, more than 25% of cases result in death or cognitive and visual impairment [1–3]. A pathophysiological symptom associated to CM is the convulsive status epilepticus, characterized by constant seizures crisis . Clinical evaluations performed in children infected with P. falciparum have described epileptic seizures associated with CM. In addition, it was showed that development of latter epilepsy in adults is a recognized sequel related with the development of CM during infancy or adolescence [5, 6]. Previous studies have already described that CM results from a complex and exacerbated inflammatory response of the infected host, which can lead to endothelial activation and disruption of blood–brain-barrier (BBB) with consequent neurodegenerative events [7–10]. It is well characterized that the development of CM is closely associated with the sequestration of infected red blood cells (iRBCs) and/or leukocytes in the cerebral microvascular endothelium leading to blood flow obstruction and decreased tissue perfusion, thereby compromising the function of distinct areas of the central nervous system (CNS), including the retinal tissue [11–15]. Although visual system represents a regular target of CM [14, 16], few studies described the neurochemicals mechanisms involved in retinal injury induced by CM. In fact, data from literature demonstrated that retinal tissue of patients with CM show an intense astrogliosis, astrocytes degeneration and microglia activation after longer periods of the disease onset [11, 12, 17]. However, it remains unclear the alterations in the retinal activity and neurotransmitters changes induced by this disease.
Retinal physiology is dependent on distinct neurotransmission systems and on the maintained redox status of the tissue [18–20]. In the retina, glutamatergic system represents the main excitatory pathway being responsible for the synaptic transmission between photoreceptor cells, bipolar cells and ganglion cells and its excessive action in different types of receptors may result in neuronal cell death by excitotoxicity . Thereby, termination of glutamatergic neurotransmission is achieved by the removal of glutamate from the extracellular space by proteins transporters located in the plasmatic membrane of pre-synaptic terminals and surrounding glial cells [22, 23]. Several reports have already demonstrated the potential involvement of glutamate-mediated cytotoxicity in both acute and chronic neurodegenerative conditions [24, 25]. In the retina, it was characterized the presence of different transporters systems which include the Na+-dependent and Na+-independent glutamate transporters . Added to this, previous studies have already showed that changes in the glutamate transport could be associated to electrophysiological response in retina and conditions of oxidative stress [27, 28].
In the CNS, including retinal tissue, the tripeptide glutathione (GSH) is the main antioxidant compound. GSH is formed by glutamate, cysteine and glycine residues and its production and release to synaptic cleft is essential for keeping the redox status in the tissue [29, 30]. In fact, it is well described that intracellular levels of GSH regulates survival and homeostasis of retinal tissue. Decrease of GSH content is associated with the induction of oxidative stress in retinal tissue and can evoke impairment of visual response [31–33]. The full-field electroretinogram (ERG) is the record of summed transient electrical responses from the entire retina elicited by a flash stimulus and is a widely used electrophysiologic test of retinal function . The standard full-field ERG for clinical investigations was established by the International Society for Clinical Electrophysiology of Vision ISCEV . The full-field ERG is essential in the diagnosis of numerous disorders as cone-rod and cone dystrophy , and diabetic retinopathy . Furthermore, the use of ERG in combination with animal models are essentials to understand the physiological changes caused by diseases that affect the visual system.
The aim of the present study was to investigate how cones photoreceptors are affected by malarial retinopathy in mice with CM. In this way, the lack of studies demonstrating the neurochemicals events and retinal activity in the pathophysiology of CM incited the development of the present work which uses C57Bl/6 mice infected with Plasmodium berghei as an experimental model.
All experimental procedures described had prior approval by the Animal Ethics Committee of the Federal University of Para (Protocol Number: 194-14/UFPA) and were conducted according to the Health Guide for the Care and Use of Laboratory Animals. All efforts were made to minimize animal suffering and to reduce the numbers of animals used. Drugs as ketamine and xylazine were used for anaesthetizing mice prior the experiments.
Male and female C57BL/6 mice (weighing 20–22 g) 6- to 8-weeks old were obtained from Animal Care Facilities of the Institute of Biological Sciences, Federal University of Para (Para, Brazil). Animals were maintained in pathogen-free conditions, housed in groups of 10 mice per cage in a light-controlled room (12:12 h light–dark cycle) and temperature (23 ± 1 °C) with food and water ad libitum.
Plasmodium berghei experimental infection
Plasmodium berghei strain ANKA were kindly provided by Evandro Chagas Institute (Para, Brazil) and maintained as frozen stocks in liquid nitrogen until the experiments. Mice were randomly divided into two groups: a non-infected control group (n = 8/experiment) and a P. berghei-infected group (n = 15/experiment). C57BL/6 mice were intraperitoneally (i.p.) injected with 106 parasitized red blood cells (pRBCs) suspended in 0.1 mL phosphate-buffered saline (PBS) pH 7.0 . Mice injected only with 0.1 mL PBS served as control group (uninfected mice). Survival and disease signs were checked daily in accordance with pre-defined humane endpoints. To evaluate the disease onset, mice were monitored twice a day for CM symptoms which consist of, at least, one of the following clinical signs of neurological involvement: poor reflexes, ataxia, limb paralysis and seizures. Behavioural changes, such as ataxia and seizures were used as humane endpoints to reduce the animal suffering. Terminal mice were anaesthetized with ketamine/xylazine (150–10 mg/kg) and killed by cervical dislocation. Parasitaemia (percentage of pRBCs) was assessed daily by microscopic counting and calculated as follows: [(number of pRBCs)/(total numbers of RBCs counted)] × 100 from Giemsa-stained thin smears obtained from tail blood.
Concentrations of tumour necrosis factor (TNF) in cortical and retinal tissue were determined by specific enzyme-linked immune assay according to standard protocol provided by the company (Biolegend). All the samples were obtained from control and P. berghei-infected mice (on day 2, 4 and 7 post-infection) and the cellular supernatant was collected and stored at − 80 °C until the time of the assay. Plates were read at 450 nm and the quantification was achieved using standards curves obtained according to manufacturer’s guide.
During different periods of infection (2, 4 and 7 days post infection) full-field electroretinography (ffERG) was performed to assess retinal function in accordance to Harazny et al. . In photopic conditions, mice were light-adapted for 10 min and stimulated with flashes of 10.2 cd s m−2 to obtain cone response. Control mice and P. berghei-infected mice were anaesthetized by injection of ketamine (100 mg/kg) and xylazine (6 mg/kg). Pupils were fully dilated with tropicamide (1%). Briefly, a silver disk electrode (model F-E6SHC-12, Grass Technologies, Warwick, USA) was placed in ear as ground, a silver ring electrode was placed on the cornea as active electrode and a subcutaneous steel needle electrode (model F-E3-48, Grass instruments, Warwick, USA) on the eyelid as reference electrode. After positioning the electrodes, the animals were placed in a Faraday cage and stimulated by visual stimulator (model PS33-PLUS, Grass Technologies, Warwick, USA). A xenon lamp (PS33-PLUS) was used to generate stimulus of white light, whose brightness was measured with digital luxmeter-photometer (Model LD-300). Intervals between stimulus was 4 s for photopic conditions with 10 ms of flashes duration. Light-evoked responses were amplified 50,000× with a AC amplifier (model P511, Grass Technologies, Warwick, USA), filtered between 0.3 and 300 Hz and digitalized with an analog–digital interface (National Instruments, Austin, TX). Data acquisition program used was Labview 3.0 (National Instruments, Austin, TX).
For each response have been issued 6–12 pulses, then the responses were based on the average response to all the white flashes presented. Amplitude (µV) was used as ERG parameters. a-wave amplitudes were measured from baseline to the a-wave trough and b-wave amplitudes were measured from the a-wave trough to the b-wave peak.
Mice from uninfected and P. berghei-infected group were perfused with PBS for 2 min and cortical brain and retinal samples were quickly removed and frozen until use. Tissues were homogenized in buffer containing protease inhibitor mixture (Sigma) and after sonication, the homogenates were centrifuged at 16,000g and the supernatant was collected. Immunoblotting was performed with standard western blot principles. 20 µg of proteins were loaded onto reducing sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and electrotransferred to a nitrocellulose membrane. The non-specific binding sites were blocked with 5% BSA in TBS-Tween for 60 min at room temperature. The blots were then incubated with NOS-2 primary antibody (1:200 in blocking solution) overnight at 4 °C. Antibody reactivity was detected using ECL-Plus chemiluminescence substrate (Amersham Pharmacia Biotech) and exposed to film (Sigma).
Intracellular levels of glutathione (GSH) were determined by the method described by Anderson  with minor modifications in the enzymatic incubation time and concentration of PBS/EDTA solution. This procedure allows to determine, spectrophotometrically, the total levels of glutathione (GSH and GSSG) by the reduction of 5,5′-dithio-bis-2-nitrobenzoic acid (DTNB) in nitrobenzoic acid (TNB). In this reaction, the sample was incubated in two different groups: the first one was incubated only with DTNB to measure the levels of –SH group and in the second one was incubated with GSH reductase (that converts GSSG into GSH), NADPH and DTNB to measure the total levels of GSH produced by the reaction. The final result is expressed by the difference between these two groups as the total levels of glutathione.
After dissection, retinal tissue from control and P. berghei-infected groups (on day 2, 4 e 7 post infection) was resuspended in PBS/EDTA (1 mM), sonicated and centrifuged at 3000 rpm, during 10 min. The supernatant was separated and an aliquot was incubated in assay solution containing PBS/EDTA (1 mM); GSH reductase (100 μ/ml) and NADPH (4 mM). After 15 min, DTNB (5 mM) was added to the reaction and the amount of TNB was measure by spectrophotometry at 412 nm. Total GSH were expressed in percentage of the control.
L-[3H]glutamate uptake assay in retinal explants
Retinal explants from control and P. berghei-infected groups were used to perform the glutamate uptake assay as described previously . To evaluate glutamate uptake, retinal explants were washed four times with modified Hank’s balanced salt solution, which consists of (in mM): NaCl 128, KCl 4, MgCl2 1, CaCl2 2, glucose 12 and HEPES 20, adjusted to pH 7.4, and then incubated with [3H]glutamate (1 µCi/ml) during 10 min. All uptake assays were performed at room temperature (37 °C) in shaking. After [3H]glutamate time incubation, the uptake was stopped by rapidly rinsing the tissue three times with ice-cold Hank’s solution and then, tissue were lysed with TCA 5% and the intracellular glutamate content was determined by liquid scintillation spectroscopy. Results were expressed in % of control. Small aliquots were removed from each well for the determination o protein content by Bradford Method.
Survival curves were compared using long-rank test. The normality test was performed using the Shapiro–Wilk test and the statistical difference between all groups was evaluated using one-way ANOVA followed by Tukey post-test. For comparisons of two groups, the Student’s t test (normally distributed) was used. Data are presented as mean ± SD and all experiments were repeated at least three times. Statistical analysis was carried out using GraphPad Prism Software and p values < 0.05 were considered significant.
Development of experimental cerebral malaria (ECM) in C57Bl/6 mice infected with Plasmodium berghei
Functional changes detected by ERG in P. berghei-infected mice are not associated with immunological activation
The electroretinographic analysis of P. berghei-infected mice demonstrated no significant changes in a- and b-wave amplitude associated to cone photopic response until 2 and 4 days post infection (Fig. 2a, b). However, a significant reduction in photopic a- and b-waves amplitudes (~ 12 and 83%, respectively) was found in P. berghei-infected mice retina at 7 days post infection (Fig. 2a, b). Representative waveforms elicited at 7 days post infection are shown in Fig. 2c.
GSH levels and glutamate uptake in retinal tissue of P. berghei-infected mice
Considering that the electrophysiological impairment observed in P. berghei-infected mice seems not to be associated with the activation of an inflammatory pathway, it was evaluated whether CM evokes neurochemicals changes in retinal tissue. Firstly, as the retinal tissue is very susceptible to oxidative stress conditions, it was determined the concentration of GSH, the main antioxidant in the central nervous system, including the retina.
Cerebral malaria is a complex and multifactorial syndrome in which pathophysiology mechanisms underlying the CNS damage, including the retina are still not fully understood. Although murine CM model has provided important insights into the pathogenesis of this syndrome , neuropathological studies have paid little attention to the neurochemicals mechanisms involved in the course of the disease. In this way, the current study demonstrated, for the first time, that CM induced by P. berghei infection evokes significant neurochemical and electrophysiological changes in mice retinal tissue.
The retinopathy associated to CM has important features as retinal whitening, vessel discoloration, haemorrhages focus and reduced perfusion as a result from the mechanical obstruction due to pRBCs sequestration [14, 40]. Previous studies, using retinal wholemounts, describes the breakdown of blood–brain barrier (BBB), petechial haemorrhages and large edema in latter stages of mice experimental CM [41, 42]. Furthermore, it was also showed that the increased BBB permeability induced by P. berghei-infection leads to a microglia thickness and a redistribution of this cell toward the retina vasculature . Increased c-fos expression evidencing an intense glial activation was also demonstrated in the retinal tissue of mice with CM, as well as, a highlighted astrogliosis and astrocytes degeneration [44, 45].
Noteworthy, the current work complements these findings showing that CM evokes functional changes in the retinal physiology which was evidenced by low photopic response (reducing a- and b-wave amplitude) observed in mice at 7 days post P. berghei infection. These results are in agreement with early observations which describe ophthalmologic dysfunctions in children with CM induced by P. falciparum infection [46, 47]. The tissue events responsible for the retinal electrophysiological impairment induced by CM are still not fully understood. However, some reports have pointed out that vessel obstruction and hypoxia generate by distinct diseases can induce visual dysfunction associated to altered response of cone photoreceptors [48–54]. Although the present work do not demonstrate a direct association between electrophysiological impairment and retinal hypoxia induced by CM, this hypothesis could be tested in posterior studies.
It was also observed that electroretinographical changes seems not to be associated to retinal inflammation since no increase on TNF levels or NOS-2 expression were observed in the retinal tissue at 7 days post-infection. The increased values of TNF and NOS-2 expression in the brain suggest that inflammatory events in the brain occur concomitantly with electrophysiological dysfunction described in retinal tissue of CM mice, but not with retinal TNF inflammation. Lou et al.  described that increased levels of TNF is an important biomarker of brain inflammation since its values are closely associated to inflammatory events in the brain such as haemorrhage events, plugging microvessels and upregulation of cellular adhesion molecules (CAMs). Besides TNF expression, several pro-inflammatory mediators such as IFN-γ, IL-1β and IL-6 contribute to the pathogenesis of CM in both humans and rodents, acting in part by increasing the expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) [56–59].
Also, previous reports have suggested that nitric oxide (NO), a product of the nitric oxide synthase enzymes (NOS), may also contribute to the pathogenesis of CM but its mechanism of action during the disease is controversial [60, 61]. Maneerat et al.  demonstrated a widespread expression of NOS-2 in different cells types in the brain during the acute phase of mice CM. Furthermore, overproduction of NO might disrupt the regulatory role of NO in CNS, leading to oxidative damage, disturbing signaling in the brain [63, 64].
Prior studies have suggested a role of oxidative stress produced both by host and parasite in the acute neurological condition development during the establishment of CM in mice [65, 66]. Further, previous reports have already showed that electrophysiological disruption in retinal tissue is accomplished to severe alterations on the redox status induced by different agents or disease conditions [67–70]. In the present study, it was demonstrated that, at 7 days post infection, CM induces an intense decrease in the GSH content, the main antioxidant in the CNS. Wright et al.  describes that GSH depletion is associated with electroretinogram alterations including decrease of a- and b-wave response in diabetic rats. The authors also describe that GSH depletion did not alter implicit time of response. It is well documented that a-wave photopic response are associated with cone photoreceptor response and that decrease of antioxidant as GSH can evoke toxicity of cone cells in the retina [71, 72]. Several factors can be associated to GSH depletion in the retinal tissue, including the generation of local oxidative stress conditions . Studies reveal that oxidant damage in retinal tissue are closely associated to glutamatergic system alterations [74–76], including the hyperstimulation of NMDA glutamate receptors which evoke excitotoxicity in retinal cells [77–79]. This excitotoxic pathway culminates in ROS production and intense consumption of intracellular GSH. In addition, it is well established that expression and activation of NOS2 enzyme is a calcium-independent mechanism related with immunological stimulation of different tissues and is not necessarily associated with glutamatergic excitotoxicity.
Added to this, previous studies also describes that alterations on the glutamate transport represents an indirect marker of glutamatergic system dysregulation of in the CNS, including the retina tissue [80–82]. In the present work, it was also demonstrated a significant increase of glutamate uptake in the retinal tissue of mice with CM. The high activity of glutamate transporters indicates a dysregulation of glutamate levels in the synaptic cleft and a consequent change in the electrical response of retinal tissue [83, 84]. Extracellular glutamate concentration controls the activation of second order neurons in retinal tissue responsible for the appearance of b-wave in the electroretinogram [83, 84]. In this way, increased activity of glutamate transporters could be associated with intense uptake of glutamate in retinal and consequent decrease of b-wave amplitude observed in our results. Previous studies have already suggested a role of glutamate neurotransmitter in the CNS dysfunction found in CM. They demonstrated increased levels of glutamate release in the brain of C57Bl/6 mice infected with P. berghei ANKA strain, being this release closely associated with neurological and behavioural symptoms in CM .
Thus, for the first time. it was demonstrated that CM induces neurochemical and electrophysiological impairment in retinal tissue and suggesting that murine model of CM can represent an important tool for pre-clinical evaluation of substances with potential protector effect against the retinal dysfunction associated to this disease.
The results presented herein show that cerebral malaria induces a decrease in the activity of cone photoreceptors in the latter stages of the disease. This decrease was also attributed to the neurochemical changes in the retinal tissue, such as the diminished levels of antioxidant glutathione and the elevated levels of glutamate neurotransmitter. Moreover, the present study demonstrated that these alterations occurred in a TNF independent manner.
KRHMO designed the study and conducted all the experiments; NF analyzed data and drafted the manuscript; LKRLP conducted electrophysiological records; ACFP conducted immunological experiments; FAFR analyzed electrophysiological records; AMHOS analysed data and JLMN designed the study. All authors read and approved the final manuscript.
We gratefully acknowledge Dra. Marinete Povoa and Instituto Evandro Chagas for providing Plasmodium berghei strain. CNPq, FAPESPA and PRO-AMAZONIA (3288/2013) for support this research.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Molyneux ME. Impact of malaria on the brain and its prevention. Lancet. 2000;355:671–2.View ArticlePubMedGoogle Scholar
- Crawley J, Smith S, Muthinji P, Marsh K, Kirkham F. Electroencephalographic and clinical features of cerebral malaria. Arch Dis Child. 2001;84:247–53.View ArticlePubMedPubMed CentralGoogle Scholar
- Shikani HJ, Freeman BD, Lisanti MP, Weiss LM, Tanowitz HB, Desruisseaux M. Cerebral malaria: we have come a long way. Am J Pathol. 2012;181:1484–92.View ArticlePubMedPubMed CentralGoogle Scholar
- Birbeck GL, Molyneux ME, Kaplan PW, Seydel KB, Chimalizeni YF, Kawaza K, et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol. 2010;9:1173–81.View ArticlePubMedPubMed CentralGoogle Scholar
- Kariuki SM, Ikumi M, Ojal J, Sadarangani M, Idro R, Olotu A, et al. Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast. Brain. 2011;134:1519–28.View ArticlePubMedPubMed CentralGoogle Scholar
- Waruiru CM, Newton CR, Forster D, New L, Winstanley P, Mwangi I, et al. Epileptic seizures and malaria in Kenyan children. Trans R Soc Trop Med Hyg. 1996;90:152–5.View ArticlePubMedGoogle Scholar
- Sumadhya DF, Chaturaka R, Senaka R. The ‘hidden’ burden of malaria: cognitive impairment following infection. Malar J. 2010;9:366.View ArticleGoogle Scholar
- Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT, et al. Evidence of blood–brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999;25:331–40.View ArticlePubMedGoogle Scholar
- Adams S, Brown H, Turner G. Breaking down the blood–brain barrier: signaling a path to cerebral malaria? Trends Parasitol. 2002;18:360–6.View ArticlePubMedGoogle Scholar
- Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003;24:491–9.View ArticlePubMedGoogle Scholar
- Medana IM, Chaudhri G, Chan-ling T, Hunt NH. Central nervous system in cerebral malaria: “innocent bystander” or active participant in the induction of immunopathology. Immunol Cell Biol. 2001;79:101–20.View ArticlePubMedGoogle Scholar
- Hunt NH, Golenser J, Chan-ling T, Parekh S, Rae C, Potter S, et al. Immunopathogenesis of cerebral malaria. Int J Parasitol. 2006;36:569–82.View ArticlePubMedGoogle Scholar
- Van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006;22:503–8.View ArticlePubMedGoogle Scholar
- Maude RJ, Dondorp AM, Sayeed AA, Day NPJ, White NJ, Beare NAV. The eye in cerebral malaria: what can it teach us? Trans R Soc Trop Med Hyg. 2009;103:661–4.View ArticlePubMedPubMed CentralGoogle Scholar
- Hora R, Kapoor P, Thind KK, Mishra PC. Cerebral malaria–clinical manifestations and pathogenesis. Metab Brain Dis. 2016;31:225–37.View ArticlePubMedGoogle Scholar
- Beare NAV, Taylor TE, Harding SP, Lewallen S, Molyneux ME. Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg. 2006;75:790–7.PubMedPubMed CentralGoogle Scholar
- Medana IM, Turner GD. Human cerebral malaria and the blood-brain barrier. Int J Parasitol. 2006;36:555–68.View ArticlePubMedGoogle Scholar
- Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci. 1990;11:462–8.View ArticlePubMedGoogle Scholar
- Imasawa M, Kashiwagi K, Iizuka Y, Tanaka M, Tsukahara S. Different expression role among glutamate transporters in rat retinal glial cells under various culture conditions. Mol Brain Res. 2005;142:1–8.View ArticlePubMedGoogle Scholar
- Benarroch EE. Glutamate transporters: diversity, function, and involvement in neurologic disease. Neurology. 2010;74:259–64.View ArticlePubMedGoogle Scholar
- Pow DV. Amino acids and their transporters in the retina. Neurochem Int. 2001;38:463–84.View ArticlePubMedGoogle Scholar
- Rauen T. Diversity of glutamate transporter expression and function in the mammalian retina. Amino Acids. 2000;19:53–62.View ArticlePubMedGoogle Scholar
- Kanai Y, Hediger MA. The glutamate and neutral amino acid transporter family: physiological and pharmacological implications. Eur J Pharmacol. 2003;31:237–47.View ArticleGoogle Scholar
- Beart PM, O’Shea RD. Transporters for l-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol. 2007;150:5–17.View ArticlePubMedGoogle Scholar
- Massieu L, García O. The role of excitotoxicity and metabolic failure in the pathogenesis of neurological disorders. Neurobiology (Bp). 1998;6:99–108.Google Scholar
- Oliveira KRM, Herculano AM, Crespo-lópez ME, do Nascimento JLM. Pharmacological characterization of glutamate Na+-independent transport in retinal cell cultures: implications in the glutathione metabolism. Neurochem Int. 2010;56:59–66.View ArticlePubMedGoogle Scholar
- Zeng K, Xu H, Chen K, Zhu J, Zhou Y, Zhang Q, et al. Effects of taurine on glutamate uptake and degradation in Müller cells under diabetic conditions via antioxidant mechanism. Mol Cell Neurosci. 2010;45:192–9.View ArticlePubMedGoogle Scholar
- Park CK, Cha J, Park SC, Lee PY, Kim JH, Kim HS, et al. Differential expression of two glutamate transporters, GLAST and GLT-1, in an experimental rat model of glaucoma. Exp Brain Res. 2009;197:101–9.View ArticlePubMedGoogle Scholar
- Cooper AJ, Kristal BS. Multiple roles of glutathione in the cental nervous system. Biol Chem. 1997;378:793–802.PubMedGoogle Scholar
- Dringen R, Gutterer JM, Hirrlinger J. Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem. 2000;267:4912–6.View ArticlePubMedGoogle Scholar
- Freitas HR, Ferraz G, Ferreira GC, Ribeiro-Resende VT, Chiarini LB, Nascimento JLM, et al. Glutathione-induced calcium shifts in chick retinal glial cells. PLoS ONE. 2016;11:1–20.Google Scholar
- Brigman JL, Powell EM, Mittleman G, Young JW. Examining the genetic and neural components of cognitive flexibility using mice. Physiol Behav. 2012;5(107):666–9.View ArticleGoogle Scholar
- Toler SM. Oxidative stress plays an important role in the pathogenesis of drug-induced retinopathy. Exp Biol Med (Maywood). 2004;229:607–15.View ArticleGoogle Scholar
- McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, et al. Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130:1–12.View ArticlePubMedGoogle Scholar
- Langwińska-Wośko E, Szulborski K, Zaleska-Żmijewska A, Szaflik J. Electrophysiological testing as a method of cone-rod and cone dystrophy diagnoses and prediction of disease progression. Doc Ophthalmol. 2015;130:103–9.View ArticlePubMedGoogle Scholar
- Pescosolido N, Barbato A, Stefanucci A, Buomprisco G. Role of electrophysiology in the early diagnosis and follow-up of diabetic retinopathy. J Diabetes Res. 2015;2015:319692.View ArticlePubMedPubMed CentralGoogle Scholar
- Harazny J, Scholz M, Buder T, Lausen B, Kremers J. Electrophysiological deficits in the retina of the DBA/2J mouse. Doc Ophthalmol. 2009;119:181–97.View ArticlePubMedGoogle Scholar
- Anderson M. Determination of glutathione and glutathione disulfide in biological sample. Methods Enzymol. 1969;113:548–55.View ArticleGoogle Scholar
- Combes V, Coltel N, Alibert M, Van Eck M, Raymond C, Juhan-Vague I, et al. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am J Pathol. 2005;166:295–302.View ArticlePubMedPubMed CentralGoogle Scholar
- Haldar K, Murphy SC, Milner DA, Taylor TE. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol. 2007;2:217–49.View ArticlePubMedGoogle Scholar
- Neill AL, Chan-Ling T, Hunt NH. Comparisons between microvascular changes in cerebral and non-cerebral malaria in mice, using the retinal whole-mount technique. Parasitology. 1993;107:477–87.View ArticlePubMedGoogle Scholar
- Chang-Ling T, Neill AL, Hunt NH. Early microvascular changes in murine cerebral malaria detected in retinal wholemounts. Am J Pathol. 1992;140:1121–30.PubMedPubMed CentralGoogle Scholar
- Medana IM, Chan-Ling T, Hunt NH. Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood–brain barrier. Am J Pathol. 2000;156:1055–65.View ArticlePubMedPubMed CentralGoogle Scholar
- Ma N, Madigan MC, Chan-Ling T, Hunt NH. Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria. Glia. 1997;19:135–51.View ArticlePubMedGoogle Scholar
- Medana IM, Chan-ling T, Hunt NH. Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood–brain barrier. Glia. 1996;16:51–64.View ArticlePubMedGoogle Scholar
- Lewallen S, Bronzan RN, Beare NA, Harding SP, Molyneux ME, Taylor TE. Using malarial retinopathy to improve the classification of children with cerebral malaria. Trans R Soc Trop Med Hyg. 2008;102:1089–94.View ArticlePubMedPubMed CentralGoogle Scholar
- Lochhead J, Movaffaghy A, Falsini B, Harding S, Riva C, Molyneux M. The effects of hypoxia on the ERG in paediatric cerebral malaria. Eye. 2010;24:259–64.View ArticlePubMedGoogle Scholar
- Frevert U, Nacer A. Fatal cerebral malaria: a venous efflux problem. Front Cell Infect Microbiol. 2014;4:155.View ArticlePubMedPubMed CentralGoogle Scholar
- Schatz A, Willmann G, Fischer MD, Schommer K, Messias A, Zrenner E, et al. Electroretinographic assessment of retinal function at high altitude. J Appl Physiol. 2013;115:365–72.View ArticlePubMedGoogle Scholar
- Huang WY, Weng WC, Peng TI, Chien YY, Wu CL, Lee M, et al. Association of hyponatremia in acute stroke stage with three-year mortality in patients with first-ever ischemic stroke. Cerebrovasc Dis. 2012;34:55–62.View ArticlePubMedGoogle Scholar
- Hoyt CS. Brain injury and the eye. Eye (Lond). 2007;21:1285–9.View ArticleGoogle Scholar
- Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23:91–147.View ArticlePubMedGoogle Scholar
- Lin YB, Liu JH, Chang Y. Hypoxia reduces the effect of photoreceptor bleaching. J Physiol Sci. 2012;62:309–15.View ArticlePubMedGoogle Scholar
- Bourque SL, Kuny S, Reyes LM, Davidge ST, Sauvé Y. Prenatal hypoxia is associated with long-term retinal dysfunction in rats. PLoS ONE. 2013;16:e61861.View ArticleGoogle Scholar
- Lou J, Lucas R, Grau GE. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev. 2001;14:810–20.View ArticlePubMedPubMed CentralGoogle Scholar
- Storm J, Craig AG. Pathogenesis of cerebral malaria—inflammation and cytoadherence. Front Cell Infect Microbiol. 2014;4:100.View ArticlePubMedPubMed CentralGoogle Scholar
- Armah H, Dodoo AK, Wiredu EK, Stiles JK, Adjei AA, Gyasi RK, et al. High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. Ann Trop Med Parasitol. 2005;99:629–47.View ArticlePubMedGoogle Scholar
- Henninger DD, Panés J, Eppihimer M, Russell J, Gerritsen M, Anderson DC, et al. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol. 1997;158:1825–32.PubMedGoogle Scholar
- Favre N, Da Laperousaz C, Ryffel B, Weiss NA, Imhof BA, Rudin W, et al. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1999;1:961–8.View ArticlePubMedGoogle Scholar
- Ong PK, Melchior B, Martins YC, Hofer A, Orjuela-Sánchez P, Cabrales P, et al. Nitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malaria. PLoS Pathog. 2013;9:e1003444.View ArticlePubMedPubMed CentralGoogle Scholar
- Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, Frangos JA, et al. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med. 2006;12:1417–22.View ArticlePubMedGoogle Scholar
- Maneerat Y, Viriyavejakul P, Punpoowong B, Jones M, Wilairatana P, Pongponratn E, et al. Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria. Histopathology. 2000;37:269–77.View ArticlePubMedGoogle Scholar
- Clark IA, Rockett KA, Burgner D. Genes, nitric oxide and malaria in African children. Trends Parasitol. 2003;19:335–7.View ArticlePubMedGoogle Scholar
- Sobolewski P, Gramaglia I, Frangos J, Intaglietta M, van der Heyde HC. Nitric oxide bioavailability in malaria. Trends Parasitol. 2005;21:415–22.View ArticlePubMedGoogle Scholar
- Reis PA, Comim CM, Hermani F, Silva B, Barichello T, Portella AC, et al. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog. 2010;6:e1000963.View ArticlePubMedPubMed CentralGoogle Scholar
- Isah MB, Ibrahim MA. The role of antioxidants treatment on the pathogenesis of malarial infections: a review. Parasitol Res. 2014;113:801–9.View ArticlePubMedGoogle Scholar
- Frey T, Antonetti DA. Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. Antioxid Redox Signal. 2011;15:1271–84.View ArticlePubMedGoogle Scholar
- Wang W, Shen H, Xie JJ, Ling J, Lu H. Neuroprotective effect of ginseng against spinal cord injury induced oxidative stress and inflammatory responses. Int J Clin Exp Med. 2015;8:3514–21.PubMedPubMed CentralGoogle Scholar
- Ha Y, Saul A, Tawfik A, Zorrilla EP, Ganapathy V, Smith SB. Diabetes accelerates retinal ganglion cell dysfunction in mice lacking sigma receptor 1. Mol Vis. 2012;18:2860–70.PubMedPubMed CentralGoogle Scholar
- Mavlyutov TA, Nickells RW, Guo LW. Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptor. Mol Vis. 2011;17:1034–43.PubMedPubMed CentralGoogle Scholar
- Wright WS, McElhatten RM, Busu C, Amit SY, Leskova W, Aw TY, et al. Influence of glutathione on the electroretinogram in diabetic and non-diabetic rats. Curr Eye Res. 2011;36:831–7.View ArticlePubMedGoogle Scholar
- Celesia GG. Anatomy and physiology of visual evoked potentials and electroretinograms. Neurol Clin. 1988;6:657–79.PubMedGoogle Scholar
- Roh YJ, Moon C, Kim SY, Park MH, Bae YC, Chun MH, et al. Glutathione depletion induces differential apoptosis in cells of mouse retina, in vivo. Neurosci Lett. 2007;7(417):266–70.View ArticleGoogle Scholar
- Izumi Y, Kirby CO, Benz AM, Olney JW, Zorumski CF. Müller cell swelling, glutamate uptake, and excitotoxic neurodegeneration in the isolated rat retina. Glia. 1999;25:379–89.View ArticlePubMedGoogle Scholar
- Mysona B, Dun Y, Duplantier J, Ganapathy V, Smith SB. Effects of hyperglycemia and oxidative stress on the glutamate transporters GLAST and system xc—in mouse retinal Müller glial cells. Cell Tissue Res. 2009;335:477–88.View ArticlePubMedPubMed CentralGoogle Scholar
- Rego AC, Santos MS, Oliveira CR. Glutamate-mediated inhibition of oxidative phosphorylation in cultured retinal cells. Neurochem Int. 2000;36:159–66.View ArticlePubMedGoogle Scholar
- Hazell AS. Astrocytes are a major target in thiamine deficiency and Wernicke’s encephalopathy. Neurochem Int. 2009;55:129–35.View ArticlePubMedGoogle Scholar
- Sheldon AL, Robinson MB. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int. 2007;2007(51):333–55.View ArticleGoogle Scholar
- Suemori S, Shimazawa M, Kawase K, Satoh M, Nagase H, Yamamoto T, et al. Metallothionein, an endogenous antioxidant, protects against retinal neuron damage in mice. Investig Ophthalmol Vis Sci. 2006;47:3975–82.View ArticleGoogle Scholar
- Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1–105.View ArticlePubMedGoogle Scholar
- Shigeri Y, Seal RP, Shimamoto K. Molecular pharmacology of glutamate transporters EAATs and VGLUTs. Brain Res Rev. 2004;45:250–65.View ArticlePubMedGoogle Scholar
- Xiong-li Yang. Characterization of receptors for glutamate and GABA in retinal neurons. Prog Neurobiol. 2004;73:127–50.View ArticleGoogle Scholar
- Sun D, Bui BV, Vingrys AJ, Kalloniatis M. Alterations in photoreceptor-bipolar cell signaling following ischemia/reperfusion in the rat retina. J Comp Neurol. 2007;1(505):131–46.View ArticleGoogle Scholar
- Gibson R, Fletcher EL, Vingrys AJ, Zhu Y, Vessey KA, Kalloniatis M. Functional and neurochemical development in the normal and degenerating mouse retina. J Comp Neurol. 2013;15(521):1251–67.View ArticleGoogle Scholar
- Miranda AS, Vieira LB, Lacerda-Queiroz N, Souza AH, Rodrigues DH, Vilela MC, et al. Increased levels of glutamate in the central nervous system are associated with behavioral symptoms in experimental malaria. Braz J Med Biol Res. 2010;43:1173–7.View ArticlePubMedGoogle Scholar